Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients
- PMID: 2398251
- DOI: 10.1097/00004836-199008000-00016
Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients
Abstract
We compared the effect of lactulose or lactitol on the fecal flora of 21 cirrhotic patients without hepatic encephalopathy. All were treated with an individualized disaccharide dose to achieve and maintain two semiliquid bowel movements per day. Stool pH and fecal flora were determined before and 10 days after stabilizing the cathartic effect. Increased counts of lactobacilli were obtained with both treatments. This increase, which was related to the decreased stool pH, was more constant with lactulose. In addition, lactitol decreased certain proteolytic bacteria such as enterococci and enterobacteria. Both total aerobic and anaerobic bacterial counts showed little quantitative variations with either treatment.
Similar articles
-
Lactulose, disaccharides and colonic flora. Clinical consequences.Drugs. 1997 Jun;53(6):930-42. doi: 10.2165/00003495-199753060-00003. Drugs. 1997. PMID: 9179525 Free PMC article. Review.
-
The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis.J Clin Gastroenterol. 1992 Sep;15(2):125-7. doi: 10.1097/00004836-199209000-00009. J Clin Gastroenterol. 1992. PMID: 1401823 Clinical Trial.
-
[Effects of lactitol on fecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy].Nihon Shokakibyo Gakkai Zasshi. 1995 Jul;92(7):1037-50. Nihon Shokakibyo Gakkai Zasshi. 1995. PMID: 7643458 Japanese.
-
Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.Hepatology. 1987 Nov-Dec;7(6):1278-84. doi: 10.1002/hep.1840070617. Hepatology. 1987. PMID: 3315932 Clinical Trial.
-
Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.Metab Brain Dis. 2016 Dec;31(6):1361-1364. doi: 10.1007/s11011-016-9910-2. Epub 2016 Sep 16. Metab Brain Dis. 2016. PMID: 27638474 Free PMC article. Review.
Cited by
-
The Intestinal Microbiota in the Development of Chronic Liver Disease: Current Status.Diagnostics (Basel). 2023 Sep 15;13(18):2960. doi: 10.3390/diagnostics13182960. Diagnostics (Basel). 2023. PMID: 37761327 Free PMC article. Review.
-
Lactulose, disaccharides and colonic flora. Clinical consequences.Drugs. 1997 Jun;53(6):930-42. doi: 10.2165/00003495-199753060-00003. Drugs. 1997. PMID: 9179525 Free PMC article. Review.
-
Pathophysiology, diagnosis, and management of hepatic encephalopathy.Inflammopharmacology. 2014 Dec;22(6):319-26. doi: 10.1007/s10787-014-0217-9. Epub 2014 Oct 10. Inflammopharmacology. 2014. PMID: 25300964 Review.
-
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis.Biosci Rep. 2023 Jun 28;43(6):BSR20222524. doi: 10.1042/BSR20222524. Biosci Rep. 2023. PMID: 37279097 Free PMC article.
-
Linkage of gut microbiome with cognition in hepatic encephalopathy.Am J Physiol Gastrointest Liver Physiol. 2012 Jan 1;302(1):G168-75. doi: 10.1152/ajpgi.00190.2011. Epub 2011 Sep 22. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 21940902 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical